Elicitation of structure-specific antibodies by epitope scaffolds

PISCES: a protein sequence culling server

Wang, G., & Dunbrack, R. L. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg224 · Cited by 1,664 · see citing works

Atomic structure of the ectodomain from HIV-1 gp41

Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., & Wiley, D. C. (1997) · Nature · doi:10.1038/387426a0 · Cited by 1,625 · see citing works

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

Wiley, D. C., Wilson, I. A., & Skehel, J. J. (1981) · Nature · doi:10.1038/289373a0 · Cited by 1,623 · see citing works

Macromolecular Modeling with Rosetta

Das, R., & Baker, D. A. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.062906.171838 · Cited by 995 · see citing works

Distribution and three-dimensional structure of AIDS virus envelope spikes

Zhu, P., Liu, J., Bess, J. W., Chertova, E. N., Lifson, J. D., Grisé, H., Ofek, G., Taylor, K. A., & Roux, K. H. (2006) · Nature · doi:10.1038/nature04817 · Cited by 776 · see citing works

Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies

Binley, J. Μ., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G. M., Kunert, R., Zolla‐Pazner, S., Katinger, H. W. D., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13232-13252.2004 · Cited by 701 · see citing works

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides

Alexander, J., Sidney, J., Southwood, S., et al. (1994) · Immunity · doi:10.1016/s1074-7613(94)80017-0 · Cited by 525 · see citing works

Structure of the Bacterial RNA Polymerase Promoter Specificity σ Subunit

Campbell, E. A., Muzzin, O., Chlenov, M., Sun, J. L., Olson, C. A., Weinman, O., Trester-Zedlitz, M., & Darst, S. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00470-7 · Cited by 492 · see citing works

MAMMOTH (Matching molecular models obtained from theory): An automated method for model comparison

Ortíz, Á. R., Strauss, C. E. M., & Olmea, O. (2002) · Protein Science · doi:10.1110/ps.0215902 · Cited by 492 · see citing works

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

Roberts, D. M., Nanda, A., Havenga, M. J. E., Abbink, P., Lynch, D. M., Ewald, B. A., Liu, J., Thorner, A. R., Swanson, P. E., Gorgone, D. A., et al. (2006) · Nature · doi:10.1038/nature04721 · Cited by 490 · see citing works

Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope

Ofek, G., Tang, M., Sambor, A., Katinger, H. W. D., Mascola, J. R., Wyatt, R. T., & Kwong, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10724-10737.2004 · Cited by 490 · see citing works

Crystal Structures of Two Sm Protein Complexes and Their Implications for the Assembly of the Spliceosomal snRNPs

Kambach, C., Walke, S., Young, R., Avis, J. M., Fortelle, E. D. L., Raker, V. A., Lührmann, R., Li, J., & Nagai, K. (1999) · Cell · doi:10.1016/s0092-8674(00)80550-4 · Cited by 475 · see citing works

Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4

Huang, C.-C., Lam, S. N., Acharya, P., Tang, M., Xiang, S.-H., Shahzad‐ul‐Hussan, S., Stanfield, R. L., Robinson, J. E., Sodroski, J., Wilson, I. A., et al. (2007) · Science · doi:10.1126/science.1145373 · Cited by 416 · see citing works

Clinical trials of antibody therapy

Glennie, M. J., & Johnson, P. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01669-8 · Cited by 290 · see citing works

Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS

Muster, T., Guinea, R., Trkola, A., et al. (1994) · Journal of Virology · doi:10.1128/jvi.68.6.4031-4034.1994 · Cited by 286 · see citing works

Crystal Structure of HIV-1 gp41 Including Both Fusion Peptide and Membrane Proximal External Regions

Buzón, V., Natrajan, G., Schibli, D. J., Campelo, F., Kozlov, M. M., & Weissenhorn, W. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000880 · Cited by 286 · see citing works

HIV-1 Broadly Neutralizing Antibody Extracts Its Epitope from a Kinked gp41 Ectodomain Region on the Viral Membrane

Sun, Z.-Y. J., Oh, K. J., Kim, M., Yu, J. C., Brusić, V., Song, L., Qiao, Z., Wang, J., Wagner, G., & Reinherz, E. L. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.018 · Cited by 279 · see citing works

Role of HIV membrane in neutralization by two broadly neutralizing antibodies

Alam, S. M., Morelli, M. J., Dennison, S. M., Liao, H., Zhang, R., Xia, S.-M., Rits‐Volloch, S., Sun, L., Harrison, S. C., Haynes, B. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908713106 · Cited by 251 · see citing works

Maturation of an Antibody Response Is Governed by Modulations in Flexibility of the Antigen-Combining Site

Manivel, V., Sahoo, N., Salunke, D. M., & Rao, K. V. S. (2000) · Immunity · doi:10.1016/s1074-7613(00)00061-3 · Cited by 189 · see citing works

The Membrane-Proximal Tryptophan-Rich Region of the HIV Glycoprotein, gp41, Forms a Well-Defined Helix in Dodecylphosphocholine Micelles,

Schibli, D. J., Montelaro, R. C., & Vogel, H. J. (2001) · Biochemistry · doi:10.1021/bi010640u · Cited by 167 · see citing works

Scorpion toxins as natural scaffolds for protein engineering.

Vita, C., Roumestand, C., Toma, F., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6404 · Cited by 154 · see citing works

Crystal structures of bacterial lipoprotein localization factors, LolA and LolB

Takeda, K., Miyatake, H., Yokota, N., Matsuyama, S., Tokuda, H., & Miki, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg324 · Cited by 148 · see citing works

Escherichia coli Methionine Aminopeptidase: Implications of Crystallographic Analyses of the Native, Mutant, and Inhibited Enzymes for the Mechanism of Catalysis ,

Lowther, W. T., Orville, A. M., Madden, D. T., Lim, S., Rich, D. H., & Matthews, B. W. (1999) · Biochemistry · doi:10.1021/bi990684r · Cited by 147 · see citing works

Structural Analysis of the Epitope of the Anti-HIV Antibody 2F5 Sheds Light into Its Mechanism of Neutralization and HIV Fusion

Barbato, G., Bianchi, E., Ingallinella, P., et al. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00611-9 · Cited by 136 · see citing works

Tertiary Structure of Proteins. I. : Representation and Computation of the Conformations

Nishikawa, K., Ooi, T., Isogai, Y., & Saitō, N. (1972) · Journal of the Physical Society of Japan · doi:10.1143/jpsj.32.1331 · Cited by 136 · see citing works

The Long Third Complementarity-Determining Region of the Heavy Chain Is Important in the Activity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5

Zwick, M. B., Komori, H. K., Stanfield, R. L., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3155-3161.2004 · Cited by 122 · see citing works

Relationship between Antibody 2F5 Neutralization of HIV-1 and Hydrophobicity of Its Heavy Chain Third Complementarity-Determining Region

Ofek, G., McKee, K., Yang, Y., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02257-09 · Cited by 113 · see citing works

Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface

Song, L., Sun, Z.-Y. J., Coleman, K. E., Zwick, M. B., Gach, J. S., Wang, J., Reinherz, E. L., Wagner, G., & Kim, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901474106 · Cited by 107 · see citing works

Scorpion-Toxin Mimics of CD4 in Complex with Human Immunodeficiency Virus gp120

Huang, C.-C., Stricher, F., Martin, L., Decker, J. M., Majeed, S., Barthe, P., Hendrickson, W. A., Robinson, J. E., Roumestand, C., Sodroski, J., et al. (2005) · Structure · doi:10.1016/j.str.2005.03.006 · Cited by 104 · see citing works

A Monomeric 3 10 -Helix Is Formed in Water by a 13-Residue Peptide Representing the Neutralizing Determinant of HIV-1 on gp41 ,

Biron, Z., Khare, S. K., Samson, A. O., et al. (2002) · Biochemistry · doi:10.1021/bi026261y · Cited by 93 · see citing works

Heat capacity changes for protein-peptide interactions in the ribonuclease S system

Varadarajan, R., Connelly, P. R., Sturtevant, J. M., & Richards, F. M. (1992) · Biochemistry · doi:10.1021/bi00120a019 · Cited by 92 · see citing works

Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding Site

Julien, J., Bryson, S., Nieva, J. L., et al. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.024 · Cited by 85 · see citing works

Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein

Liang, X. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00125-5 · Cited by 83 · see citing works

The Crystal Structure of Lipase II from Rhizopus niveus at 2.2 A Resolution

Kohno, M., Funatsu, J., Mikami, B., et al. (1996) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021442 · Cited by 80 · see citing works

Ablation of the Complementarity-Determining Region H3 Apex of the Anti-HIV-1 Broadly Neutralizing Antibody 2F5 Abrogates Neutralizing Capacity without Affecting Core Epitope Binding

Julien, J., Huarte, N., Maeso, R., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02357-09 · Cited by 73 · see citing works

Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope

Arnold, G. F., Velasco, P. K., Holmes, A. K., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00184-09 · Cited by 68 · see citing works

Structure of the HIV-1 gp41 Membrane-Proximal Ectodomain Region in a Putative Prefusion Conformation,

Liu, J., Deng, Y., Dey, A., Moore, J. P., & Lu, M. (2009) · Biochemistry · doi:10.1021/bi802303b · Cited by 62 · see citing works

Induction of Mucosal and Systemic Neutralizing Antibodies against Human Immunodeficiency Virus Type 1 (HIV-1) by Oral Immunization with Bovine Papillomavirus-HIV-1 gp41 Chimeric Virus-Like Particles

Zhang, H., Huang, Y., Fayad, R., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8342-8348.2004 · Cited by 58 · see citing works

Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate

Chakrabarti, B. K., Xu, L., Yang, Z.-Y., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.099 · Cited by 54 · see citing works

Thermodynamic and Structural Consequences of Changing a Sulfur Atom to a Methylene Group in the M13Nle Mutation in Ribonuclease-S

Thomson, J. L., Ratnaparkhi, G. S., Varadarajan, R., et al. (1994) · Biochemistry · doi:10.1021/bi00194a025 · Cited by 46 · see citing works

Tertiary Structure of Proteins

Frauenfelder, H. (2010) · Biological and medical physics, biomedical engineering · doi:10.1007/978-1-4419-1044-8_9 · Cited by 9 · see citing works

DNA recognition of a 24-mer peptide derived from RecA protein

Sugimoto, N. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:6 · Cited by 5 · see citing works

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

McLellan, J. S., Chen, M., Joyce, M. G., Sastry, M., Stewart-Jones, G. B. E., Yang, Y., Zhang, B., Chen, L., Srivatsan, S., Zheng, A., et al. (2013) · Science · doi:10.1126/science.1243283 · Cited by 1,126 · see citing works

Proof of principle for epitope-focused vaccine design

Correia, B. E., Bates, J. T., Loomis, R. J., Baneyx, G., Carrico, C., Jardine, J. G., Rupert, P., Correnti, C., Kalyuzhniy, O., Vittal, V., et al. (2014) · Nature · doi:10.1038/nature12966 · Cited by 555 · see citing works

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

Graham, B. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00972.x · Cited by 239 · see citing works

Structure-Based Vaccine Antigen Design

Graham, B. S., Gilman, M. S. A., & McLellan, J. S. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-121217-094234 · Cited by 234 · see citing works

De novo protein design enables the precise induction of RSV-neutralizing antibodies

Sesterhenn, F., Yang, C., Bonet, J., Cramer, J. T., Wen, X., Wang, Y., Chiang, C.-I., Abriata, L. A., Kucharska, I., Castoro, G., et al. (2020) · Science · doi:10.1126/science.aay5051 · Cited by 191 · see citing works

A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells

Procko, E., Berguig, G. Y., Shen, B. W., Song, Y., Frayo, S., Convertine, A. J., Margineantu, D., Booth, G., Correia, B. E., Cheng, Y., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.034 · Cited by 127 · see citing works

<i>AbDesign</i>: An algorithm for combinatorial backbone design guided by natural conformations and sequences: Combinatorial Backbone Design in Antibodies

Lapidoth, G. D., Baran, D., Pszolla, G. M., Norn, C., Alon, A., Tyka, M. D., & Fleishman, S. J. (2015) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24779 · Cited by 107 · see citing works

Conserved and Exposed Epitopes on Intact, Native, Primary Human Immunodeficiency Virus Type 1 Virions of Group M

Nyambi, P. N., Mbah, H. A., Burda, S. T., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.7096-7107.2000 · Cited by 140 · see citing works

Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein

Hicar, M. D., Chen, X., Sulli, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158861 · Cited by 10 · see citing works

Linear Epitopes of HIV-1, Presented as Hybrids with Escherichia Coli β-Galactosidase or Synthetic Peptides

Isaguliants, M. G., Ll, S., Levi, M., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.655 · Cited by 2 · see citing works

[Composition of HIV-1 B-epitopes and heterologous T-cell epitopes. I. Maintenance of antigenic properties of HIV-1 B-epitopes].

Mg, I., Koshida, R., Rudén, U., et al. (1996) · PubMed

Induction of multi-epitopespecific antibodies against HIV-1 by multi-epitopevaccines

Ding, J., He, F., Lu, Y., et al. (2001) · Chinese Science Bulletin · doi:10.1007/bf02901157 · Cited by 9 · see citing works